Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelates

Authors: Qu Z.; Sharkey R.M.; Hansen H.J.; Shih L.B.; Govindan S.V.; Shen J.; Goldenberg D.M.; Leung S.-o.

Source: Journal of Immunological Methods, Volume 213, Number 2, June 1998 , pp. 131-144(14)

Publisher: Elsevier

Keywords: Human; Antibodies; Immunoconjugates; Oligosaccharides; Immunotherapy

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0022-1759(97)00192-0

Affiliations: 1: Immunomedics, Morris Plains, NJ 07950, USA

Publication date: 1998-06-01

• In this: publication
• By this: publisher
• In this Subject: Microbiology ,  Allergy & Immunology
• By this author: Qu Z. ;  Sharkey R.M. ;  Hansen H.J. ;  Shih L.B. ;  Govindan S.V. ;  Shen J. ;  Goldenberg D.M. ;  Leung S.-o.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers